1. Israilides C, Kletsas D, Arapoglou D, et al. In vitro cytostatic andimmunomodulatory properties of the medicinal mushroom Lentinula edodes .Phytomedicine . 2008;15(6-7):512-519
.2. Tanabe H, Imai N, TakechiK. Studies on usefulness of postoperative adjuvant chemotherapy withlentinan in patients with gastrointestinal cancer [in Japanese]. Nippon
Gan Chiryo Gakki Shi . 1990;25(8):1657-1667.
3. Suzuki M, Higuchi S,Taki Y, Taki S, Miwa K, Hamuro J. Induction of endogenouslymphokine-activated killer activity by combined administration oflentinan and interleukin 2. Int J Immunopharmacol . 1990;12(6):613-623.
4.Hazama S, Oka M, Yoshino S, et al. Clinical effects and immunologicalanalysis of intraabdominal and intrapleural injection of lentinan for
malignant ascites and pleural effusion of gastric carcinoma [inJapanese]. Gan To Kagaku Ryoho . 1995;22(11):1595-1597.
5. Lee JY,Kim JY, Lee YG, Rhee MH, Hong EK, Cho JY. Molecular mechanism ofmacrophage activation by Exopolysaccharides from liquid culture ofLentinus edodes . J Microbiol Biotechnol . 2008;18(2):355-364.
6.Péter G, Károly V, Imre B, János F, Kaneko Y. Effects of lentian oncytotoxic functions of human lymphocytes. Immunopharmacol Immunotoxical .1988;10(2):157-163.
7. Takeshita K, Saito N, Sato Y, et al.Diversity of complement activation of lentinan, an antitumorpolysaccharide, in gastric cancer patients [in Japanese]. Nippon GekaGakkai Zasshi . 1991;92(1):5-11.
8. Tani M, Tanimura H, Yamaue H, etal. Augmentation of lymphokine-activated killer cell activity bylentinan. Anticancer Res . 1993;13(5C):1773-1776.
9. Tani M, TanimuraH Yamaue H, et al. In vitro generation of activated natural killer cellsand cytotoxic macrophages with lentinan. Eur J Clin Pharmacol .1992;42(6):623-627.
10. Arinaga S, Karimine N, Takamuku K, et al.Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma. Int JImmunopharm . 1992;14(4):535-539.
11. Arinaga S, Karimine N, NanbaraS, et al. Enhanced production of interleukin 1 and tumor necrosis factor
by peripheral monocytes after lentinan administration in patients withgastric carcinoma. Int J Immunopharm . 1992;14(1):43-47.
12. AkamatsuS, Watanabe A, Tamesada M, et al. Hepatoprotective effect of extractsfrom Lentinus edodes mycelia on dimethylnitrosamine-induced liverinjury. Biol Pharm Bull . 2004;27(12):1957-1960.
13. Ng ML, Yap AT.Inhibition of human colon carcinoma development by lentinan fromshiitake mushrooms (Lentinus edodes). J Altern Complement Med2002;8(5):581-589.
14. Okamoto T, Kodoi R, Nonaka Y, et al. Lentinan
from shiitake mushroom (Lentinus edodes) suppresses expression ofcytochrome P450 1A subfamily in the mouse liver. Biofactors.2004;21(1-4):407-409.
15. Ngai PH, Ng TB. Lentin, a novel and potentantifungal protein from shitake mushroom with inhibitory effects on
activity of human immunodeficiency virus-1 reverse transcriptase andproliferation of leukemia cells. Life Sci. Nov 14 2003;73(26):3363-3374.
16.Israilides C, Kletsas D, Arapoglou D, et al. In vitro cytostatic andimmunomodulatory properties of the medicinal mushroom Lentinula edodes.Phytomedicine 2008.
17. Akamatsu S, Watanabe A, Tamesada M, et al.Hepatoprotective effect of extracts from Lentinus edodes mycelia ondimethylnitrosamine-induced liver injury. Biol Pharm Bull.2004;27(12):1957-1960.
18. de Lima PL, Delmanto RD, Sugui MM, et al.Letinula edodes (Berk.) Pegler (Shiitake) modulates genotoxic and mutagenic effects induced by alkylating agents in vivo. Mutat Res.
2001;496(1-2):23-32.
19. Shouji N, Takada K, Fukushima K, Hirasawa M.
Anticaries effect of a component from shiitake (an edible mushroom).Caries Res 2000;34(1):94-98.
20. deVere White RW, Hackman RM, Soares
SE, Beckett LA, Sun B. Effects of a mushroom mycelium extract on thetreatment of prostate cancer. Urology 2002;60(4):640-644.
21. GordonM, Bihari B, Goosby E, et al. A placebo-controlled trial of the immunemodulator, lentinan, in HIV-positive patients: a phase I/II trial. J Med1998;29(5-6):305-330.
22. Yang P, Liang M, Zhang Y, Shen B (August2008). "Clinical application of a combination therapy of lentinan,
multi-electrode RFA and TACE in HCC". Advances in Therapy 25 (8):787–94. doi:10.1007/s12325-008-0079-x. PMID 18670743.
23. Nimura H,Mitsumori N, Takahashi N (June 2006). "[S-1 combined with lentinan inpatients with unresectable or recurrent gastric cancer]" (in Japanese).Gan to Kagaku Ryoho 33 Suppl 1: 106–9. PMID 16897983.
24. Nakano H,Namatame K, Nemoto H, Motohashi H, Nishiyama K, Kumada K (1999). "Amulti-institutional prospective study of lentinan in advanced gastriccancer patients with unresectable and recurrent diseases: effect onprolongation of survival and improvement of quality of life. Kanagawa
Lentinan Research Group". Hepato-gastroenterology 46 (28): 2662–8. PMID10522061.
25. Oba K, Kobayashi M, Matsui T, Kodera Y, Sakamoto J
(July 2009). "Individual patient based meta-analysis of lentinan forunresectable/recurrent gastric cancer". Anticancer Research 29 (7):
2739–45. PMID 19596954.http://ar.iiarjournals.org/cgi/pmidlookup?view=long&pmid=19596954.
26.Hazama S, Watanabe S, Ohashi M (July 2009). "Efficacy of orallyadministered superfine dispersed lentinan (beta-1,3-glucan) for thetreatment of advanced colorectal cancer". Anticancer Research 29 (7):2611–7. PMID 19596936.
http://ar.iiarjournals.org/cgi/pmidlookup?view=long&pmid=19596936.
27.Kataoka H, Shimura T, Mizoshita T (2009). "Lentinan with S-1 andpaclitaxel for gastric cancer chemotherapy improve patient quality oflife". Hepato-gastroenterology 56 (90): 547–50. PMID 19579640.
28.Isoda N, Eguchi Y, Nukaya H (2009). "Clinical efficacy of superfinedispersed lentinan (beta-1,3-glucan) in patients with hepatocellularcarcinoma". Hepato-gastroenterology 56 (90): 437–41. PMID 19579616.
29.Shimizu K, Watanabe S, Watanabe S (2009). "Efficacy of oral
administered superfine dispersed lentinan for advanced pancreaticcancer". Hepato-gastroenterology 56 (89): 240–4. PMID 19453066.
30.Sullivan R, Smith JE, Rowan NJ. Medicinal mushrooms and cancer therapy:translating a traditional practice into Western medicine. Perspect BiolMed . 2006;49(2):159-170.